MeSH D016066 - malignant pleural effusion
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Helsinn Birex Pharmaceuticals | Mechlorethamine | Valchlor | 2026-03-07 | 2013-08-23 | ||
| Mechlorethamine | Ledaga | 2017-03-03 | ||||
| Recordati | Mechlorethamine | Mustargen | 1982-01-01 |
Clinical Trials
Historical Success Rate
Phase 1
62%13/21
Phase 2
29%7/24
Phase 3
67%6/9
Approved: 2Overall Success rate: 12%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use